AKEBIA THERAPEUTICS INC (AKBA) Institutional Ownership Changes & 13F Activity
AKEBIA THERAPEUTICS INC (AKBA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Baupost Group, and Abrams Capital Management.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | Renaissance Technologies LLC | Sell | -1,760,005 | 1,833,128 | $2,548,048 |
| Q4 2025 | Renaissance Technologies LLC | Sell | -359,594 | 3,593,133 | $5,784,944 |
| Q3 2025 | Renaissance Technologies LLC | Sell | -241,700 | 3,952,727 | $10,790,945 |
| Q2 2025 | Renaissance Technologies LLC | Buy | 188,600 | 4,194,427 | $15,267,714 |
| Q1 2025 | Renaissance Technologies LLC | Buy | 182,300 | 4,005,827 | $7,691,188 |
| Q4 2024 | Renaissance Technologies LLC | Buy | 105,727 | 3,823,527 | $7,264,701 |
| Q3 2024 | Renaissance Technologies LLC | Sell | -197,000 | 3,717,800 | $4,907,496 |
| Q2 2024 | Renaissance Technologies LLC | Buy | 262,700 | 3,914,800 | $3,993,096 |
| Q1 2024 | Renaissance Technologies LLC | Sell | -1,127,283 | 3,652,100 | $6,683 |
| Q4 2023 | Renaissance Technologies LLC | Buy | 1,623,956 | 4,779,383 | $5,926 |
| Q3 2023 | Renaissance Technologies LLC | Sell | -175,300 | 3,155,427 | $3,597 |
| Q2 2023 | Renaissance Technologies LLC | Buy | 992,227 | 3,330,727 | $3,048 |
| Q1 2023 | Renaissance Technologies LLC | Sell | -547,727 | 2,338,500 | $1,310 |
| Q4 2022 | Renaissance Technologies LLC | Sell | -130,200 | 2,886,227 | $1,665 |
| Q3 2022 | Renaissance Technologies LLC | Buy | 1,534,127 | 3,016,427 | $954 |
| Q2 2022 | Renaissance Technologies LLC | Buy | 478,973 | 1,482,300 | $523 |
| Q1 2022 | Renaissance Technologies LLC | Buy | 380,300 | 1,003,327 | $720 |
| Q4 2021 | Renaissance Technologies LLC | Sell | -326,900 | 623,027 | $1,408 |
| Q3 2021 | Renaissance Technologies LLC | Sell | -877,803 | 949,927 | $2,736 |
| Q2 2021 | Renaissance Technologies LLC | Buy | 757,149 | 1,827,730 | $6,927 |
| Q1 2021 | Renaissance Technologies LLC | Sell | -377,346 | 1,070,581 | $3,624 |
| Q4 2020 | Renaissance Technologies LLC | Buy | 1,377,752 | 1,447,927 | $4,054 |
| Q3 2020 | Renaissance Technologies LLC | Sell | -5,514 | 70,175 | $176 |
| Q2 2020 | Baupost Group | Sell | -2,527,968 | 15,000,000 | $203,700 |
| Q2 2020 | Renaissance Technologies LLC | Sell | -62,838 | 75,689 | $1,028 |
| Q1 2020 | Baupost Group | Sell | -2,043,485 | 17,527,968 | $132,862 |
| Q4 2019 | Baupost Group | Sell | -4,900,000 | 19,571,453 | $123,692 |
| Q4 2019 | Renaissance Technologies LLC | Buy | 95,100 | 138,527 | $875 |
| Q3 2019 | Renaissance Technologies LLC | Sell | -1,733,544 | 43,427 | $170 |
| Q4 2018 | Baupost Group | Buy | 24,471,453 | 24,471,453 | $135,327 |
Frequently asked questions about AKBA activity
Which institutional owners are buying AKBA?
Institutional owners buying AKBA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AKBA activity?
"Buy" means an investor increased their reported position in AKBA compared to the prior reporting period. This reflects growing exposure to AKEBIA THERAPEUTICS INC (AKBA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AKBA increasing?
Institutional interest in AKBA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related AKBA Institutional Insights
- AKBA Institutional Ownership Overview
- AKBA Institutional Ownership & Insiders Activity
- AKBA Institutional Ownership & 13F Activity
- AKBA Top Institutional Shareholders
- AKBA Institutional Buying Activity
- AKBA Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AKBA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings